BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8543980)

  • 1. Concept of reaction volume in the in vivo ligand-receptor model.
    Delforge J; Syrota A; Bendriem B
    J Nucl Med; 1996 Jan; 37(1):118-25. PubMed ID: 8543980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two compartmental models for describing receptor ligand kinetics and receptor availability in multiple injection PET studies.
    Morris ED; Alpert NM; Fischman AJ
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):841-53. PubMed ID: 8784229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute quantification by positron emission tomography of the endogenous ligand.
    Delforge J; Bottlaender M; Pappata S; Loc'h C; Syrota A
    J Cereb Blood Flow Metab; 2001 May; 21(5):613-30. PubMed ID: 11333372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic evaluation of positron-emitting muscarinic receptor ligands employing direct intracarotid injection.
    Buck A; Mulholland GK; Papadopoulos SM; Koeppe RA; Frey KA
    J Cereb Blood Flow Metab; 1996 Nov; 16(6):1280-7. PubMed ID: 8898702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ab initio computational study of positron emission tomography ligands interacting with lipid molecule for the prediction of nonspecific binding.
    Rosso L; Gee AD; Gould IR
    J Comput Chem; 2008 Nov; 29(14):2397-405. PubMed ID: 18442082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands.
    Szegletes T; Mallender WD; Rosenberry TL
    Biochemistry; 1998 Mar; 37(12):4206-16. PubMed ID: 9521743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple and convenient approach for evaluation of the parameters of ligand-receptor interaction. Receptor blocking index and its application.
    Bobrovnik SA
    J Mol Recognit; 2008; 21(2):96-102. PubMed ID: 18383099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol.
    Delforge J; Pappata S; Millet P; Samson Y; Bendriem B; Jobert A; Crouzel C; Syrota A
    J Cereb Blood Flow Metab; 1995 Mar; 15(2):284-300. PubMed ID: 7860662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach.
    Delforge J; Bottlaender M; Loc'h C; Guenther I; Fuseau C; Bendriem B; Syrota A; Mazière B
    J Cereb Blood Flow Metab; 1999 May; 19(5):533-46. PubMed ID: 10326721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple receptor populations: binding isotherms and their numerical analysis.
    Pliska V
    J Recept Signal Transduct Res; 1995; 15(1-4):651-75. PubMed ID: 8903971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis.
    Blomqvist G
    Wien Klin Wochenschr; 1991; 103(15):451-7. PubMed ID: 1926871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Numerical analysis of a model of ligand-induced B-cell antigen-receptor clustering. Implications for simple models of B-cell activation in an immune network.
    Faro J; Velasco S
    J Theor Biol; 1994 Mar; 167(1):45-53. PubMed ID: 8176953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of ligand-receptor binding using SPME: investigation of receptor, free, and total ligand concentrations.
    Musteata FM; Pawliszyn J
    J Proteome Res; 2005; 4(3):789-800. PubMed ID: 15952725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rigorous multiple independent binding site model for determining cell-based equilibrium dissociation constants.
    Drake AW; Klakamp SL
    J Immunol Methods; 2007 Jan; 318(1-2):147-52. PubMed ID: 17141800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic considerations in the PET and SPECT evaluation of CNS receptors.
    Mazière B; Delforge J
    Q J Nucl Med; 1997 Jun; 41(2):119-26. PubMed ID: 9203851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple and rapid orientation procedure for the estimation of affinities (1/Kd) and maximum binding capacities (Bmax) of ligand binding to two receptor subpopulations.
    Hynie S; Bojar S; Klenerová V; Wenke M
    Physiol Bohemoslov; 1986; 35(4):299-307. PubMed ID: 3020601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifiability analysis and parameter identification of an in vivo ligand-receptor model from PET data.
    Delforge J; Syrota A; Mazoyer BM
    IEEE Trans Biomed Eng; 1990 Jul; 37(7):653-61. PubMed ID: 2394453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction of the ligand molecules with the membrane receptors of tumor cells].
    Kaz'min SD
    Eksp Onkol; 1989; 11(2):25-8. PubMed ID: 2544393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining methods for calculations of binding free energies: LRA, LIE, PDLD-LRA, and PDLD/S-LRA calculations of ligands binding to an HIV protease.
    Sham YY; Chu ZT; Tao H; Warshel A
    Proteins; 2000 Jun; 39(4):393-407. PubMed ID: 10813821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo receptor assay with multiple ligand concentrations: an equilibrium approach.
    Holden JE; Jivan S; Ruth TJ; Doudet DJ
    J Cereb Blood Flow Metab; 2002 Sep; 22(9):1132-41. PubMed ID: 12218419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.